Other Body1 KnowCo's: Empower your Life™
Back1 Body1 Dental1 Diabetes1 Fibroids1 Knee1 MedTech1 Reflux1 Shoulder1 Uterus1 Veins1 Wounds1
Body1
 Register
 Login
 Main Page
 Heart News
Feature Story
 Education Center
Conditions
Procedures
Diagnostics
 Heart Attack Center
Prevention
Survivors
Dr. Juerg Schmidli  Heart
 Hero™

Dr. Juerg Schmidli:
Revolutionizing Blood Pressure Care.
About Heroes
 Join the Discussion  in  Our Forums
 Community
Heart1 Forums
Patient Stories
 Reference
Online Resources
Video Library
advertisement
advertisement
Search the Body1 Network
   
August 29, 2008  
EDUCATION CENTER: Heart Procedures
  • Printer Friendly Version
  • Email this Procedure
  • Links/Reprints
  • Surgical Ventricular Restoration

    Overview
    Reviewed by Dr. Stanley Forwand

    Surgical ventricular restoration is an operation performed on patients with congestive heart failure who have developed scarring or aneurysms in the heart wall and an enlarged heart.

    This procedure is used when a weakness is located in the heart, usually in the front part of the heart.

    Also known as SAVER (surgical anterior ventricular endocardial restoration), SVR directly addresses the underlying cause for CHF by changing the anatomy of the left ventricle, the heart’s main pumping chamber. Restoring the normal size and shape of the left ventricle and fiber orientation with SVR allows for more normal heart muscle function.

    Detailed Description
    When a patient has a major heart attack, frequently there is scarring or full thickness loss of heart muscle wall and the muscle becomes replaced by scar tissue. The scar tissue, which does not contract like normal heart muscle, tends to expand.

    As the left ventricle and the heart become larger, or dilated, it becomes less efficient as a pumping chamber and the patient goes into progressive heart failure. The predominant cause of disease and death in CHF is ventricular dilation. SVR is one of several operations designed to address this problem.

    SVR is a surgical procedure that decreases the size of the left ventricle. The purpose of this operation is to improve the heart’s ability to pump blood throughout the body. It helps decrease stress on the weak heart muscle.

    SVR returns the abnormally shaped left ventricle to the more normal elliptical shape and muscle fibers to a more helical fiber orientation, thereby improving heart function, by lowering wall stress and permitting the normal heart to “twist” in its natural movement.

    The procedure is performed in conjunction with other operations. The operation itself adds about 20-30 minutes to a regular open-heart surgery that might include bypass and valve replacement.

    The Procedure

    Before surgery, doctors try to determine the transition area between functioning heart muscle and scar tissue. Then, they aim to reconstruct the heart based on that area of functionality.

    After making an incision into the ventricle, an encircling suture is used to exclude scarred tissue overlying the transition zone. After tightening the suture, an oval rim is formed with a raised edge. The opening is then closed with a patch in most cases or by a direct closure.

    After a group of heart surgeons in Alabama found 75% of 421 patients were functionally free from heart failure, with a great improvement in their quality of life, 18 months after SVR, experts are saying the operation is “safe and effective.”

    The study also showed 89% of patients were still alive, and 85% of them had avoided readmission to hospital for congestive heart failure.

    The paper was published in the April 2001 Journal of the American College of Cardiology.

    Candidates for SVR, include those with severe heart failure, a very enlarged heart, and areas of scarring that’s causing heart failure to worsen. Those who aren’t candidates for a heart transplant, such as the elderly or those with diabetes may otherwise be eligible for SVR.

    Investigators are currently performing SVR and other heart therapies in an international, multi-center, randomized trial, dubbed STICH, which is sponsored by the National Institutes of Health. The goal of the trial is to determine the best treatment for patients with heart failure caused by coronary artery disease.

    Last updated: 28-Apr-03

    Comments

  • Add Comment
  •    
     
    Interact on Heart1

    Discuss this topic with others.
     
    Related Multimedia

    The risk of cardiac death due to a lower ejection fraction

    The function of a defibrillator

    Plags/fatty deposits as a cause for a heart attack

    More Features ...
     
    Related Content
    Hypertensive Blacks May Have Thick Hearts

    New Device Helps Reshape Damaged Hearts

    Enlarged Heart

    Endocarditis

    Coronary Artery Disease (CAD)

    More Features ...
     
    Home About Us Press Jobs Advertise With Us Contact Us
    advertisement
    ©1999- 2008 Body1, Inc. All rights reserved.
    Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.
    See our Terms of Service, our Privacy Policy, our Advertising Policy and our Editorial Policy.